Overview

A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to establish if the same amount of drug is absorbed into the blood after ingesting a combination dapagliflozin/metformin tablet vs. the individual dapagliflozin tablet and individual metformin tablet.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Bristol-Myers Squibb
Treatments:
Dapagliflozin
Metformin